In context
Palmitoyl pentapeptide-4 was incorporated into an experimental dendrimer delivery system designed to release active ingredients under skin-related conditions. [1]
At a glance
- Type
- Topical cosmetic ingredient
- Regulatory context
- The cited source describes research, not a determination of present marketing authorisation. Country, formulation and indication must be checked separately.
- Evidence
- This is formulation and delivery research. It does not establish that all creams containing the ingredient produce the same clinical effect.
How to interpret this evidence
This is formulation and delivery research. It does not establish that all creams containing the ingredient produce the same clinical effect. [1]
Safety and clinical context
Topical cosmetic research does not support injection or other systemic use. Safety and tolerability depend on the complete formulation and the person using it.
Evidence and authorisation depend on the product, formulation, indication and country. US labelling does not establish Thai authorisation. This guide is educational and is not a dosing or self-treatment protocol.
Primary sources
Read the underlying source and its limitations. A study citation does not by itself establish efficacy or approval.